Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.

Chen, Bo; Deng, Tuo; Deng, Liming; Yu, Haitao; He, Bangjie; Chen, Kaiyu; Zheng, Chongming; Wang, Daojie; Wang, Yi; Chen, Gang

Chen, Bo; Deng, Tuo; Deng, Liming; Yu, Haitao; He, Bangjie; Chen, Kaiyu; Zheng, Chongming; Wang, Daojie; Wang, Yi; Chen, Gang.

Afiliación

Chen B; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Deng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Deng L; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yu H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
He B; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chen K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zheng C; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang D; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang Y; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chen G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

BMC Cancer ; 21(1): 1211, 2021 Nov 12.

Article en En | MEDLINE | ID: mdl-34772375

Asunto(s)

Adenocarcinoma; Empalme Alternativo; Neoplasias Pancreáticas; Microambiente Tumoral; Adenocarcinoma/genética; Adenocarcinoma/inmunología; Adenocarcinoma/mortalidad; Anciano; Algoritmos; Antígenos B7/metabolismo; Antígeno B7-H1/metabolismo; Linfocitos T CD4-Positivos; Antígeno CD47/metabolismo; Linfocitos T CD8-positivos; Carcinoma Ductal Pancreático/genética; Carcinoma Ductal Pancreático/inmunología; Carcinoma Ductal Pancreático/mortalidad; Femenino; Humanos; Proteínas de Punto de Control Inmunitario/genética; Inmunidad Celular; Estimación de Kaplan-Meier; Masculino; Persona de Mediana Edad; Mutación; Nomogramas; Neoplasias Pancreáticas/genética; Neoplasias Pancreáticas/inmunología; Neoplasias Pancreáticas/mortalidad; Pronóstico; Modelos de Riesgos Proporcionales; Factores de Empalme de ARN/metabolismo; Receptores Virales/metabolismo; Linfocitos T Reguladores; Microambiente Tumoral/genética; Microambiente Tumoral/inmunología

Palabras clave

Alternative splicing; Immunotherapy; Pancreatic adenocarcinoma; Prognosis; Tumour immune microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Empalme Alternativo / Microambiente Tumoral Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google